Objective:To explore the clinical effect and safety of Yikunning granules combined with tibolone and paroxetine in the treatment of female patients with menopausal syndrome. Methods:Totally 150 female patients with menopausal syndrome were randomly divided into the control group (75 cases) and the study group (75 cases). The control group was orally given tibolone (2. 5mg,po,qd) and paroxetine tablets (20mg,po,qd), and the study group was treated with Yikunning granules additionally (3g,po,tid). After 3-month treatment, the modified Kupperman score was used to evaluate the clinical symptoms, radioimmunoassay was used to detect the serum lev-els of estradiol (E2), luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL) and progesterone (P), and the adverse reactions were recorded. Results:After the treatment, most of the indices in the modified Kupperman score were improved in the two groups (P<0. 05). In the study group, such symptoms as hot flashes and perspiration, anxiety, depression and palpitations, and the general score were improved more notable than those in the control group(P<0. 05). After the treatment, serum levels of E2 was in-creased, while FSH and PRL were decreased(P<0. 05), and PRL and P were unchanged (P>0. 05). The improvement of E2, LH and FSH in the study group was better than that in the control group (P<0. 05). There was no significant difference in the adverse reactions between the two groups (P<0. 05). Conclusion:Yikunning granules combined with tibolone and paroxetine show good effectiveness in the treatment of menopausal syndrome with improved clinical symptom and sex hormone levels, which is worthy of promotion.

In recent years, there has been a gradual increase in treatment options for patients with esophageal cancer. While surgery remains to be the primary treatment, neoadjuvant and adjuvant therapy, both preoperatively and postoperatively, have become more important in the multidisciplinary treatment of resectable esophageal cancer. Definitive concomitant chemo-radiotherapy may replace surgery as the primary treatment for resectable esophageal cancer. Cisplatin combined with 5-fluorouracil remains the backbone regimen for neoadjuvant and adjuvant therapy. Intense researches are underway to investigate new cytotoxic drugs such as taxanes and topoisomerase inhibitor, and new regimens for perioperative treatment of resectable esophageal cancer.

Cisplatin in combination with fluorouracil still is considered as the basic therapeutic scheme for advanced esophageal cancer. New cytotoxic drugs, such as taxanes and topoisomerase inhibitor etc, and new regimens are focus researches for medical treatment. Intravenous fluorouracil can be replaced by oral fluorouracil derivative, and cisplatin can be replaced by oxaliplatin in the regimens of contained cisplatin and fluorouracil for advanced esophageal cancer. Patients with advanced esophageal cancer are now offered seconded line treatment, and the number of research protocols is increasing. Molecule targeted therapy as a promising treatment will provide more and better options for patients.

Endocrine therapy is the most important systemic therapy for hormone receptor positive breast cancer.However,intrinsic or acquired resistance to endocrine therapy is a challenge currently.Crosstalk between estrogen receptor pathway and other pathway is considered to be one of the underlying mechanisms.Progress has been made in reversing resistance by blocking signaling through pathways such as the phosphoinositide 3-kinasesprotein kinase B-mammalian target of rapamycin and epidermal growth factor receptor pathway.

Poly ADP-Ribose Polymerase(PARP)plays an important role in the detection and repair of DNA damage.Inhibition of the PARP activity in the homologous-recombination defective cancer cell could lead to genomic instability and ultimately cause cell death.In preclinical study PARP inhibitors have demonstrated the capacity of enhancing sensitivity of cancel cells to chemotherapy agents and radiation.PARP inhibitors also showed antitumour potential in early clinical trials as monotherapy or combined with chemotherapy.

Anthracycline-based chemotherapeutic agents were extensively applied to the treatment of breast cancer. The relation of its response to TOP2A gene was proved by a number of clinical studies demonstrating that patients with both HER2 gene amplification and TOP2A gene aberration have a favored outcome,but a consensus was not yet achieved.

Objective To promote the cure rate of operation and to decrease the operative complications in patients with upper urinary tract stone Methods The data of 962 patients with upper urinary tract stone operatively treated in our department from 1975 to 2002 were reviewed and analyzed Results Residual stones were found in 109 out of 673 patients (11 3 %) Of the 109 cases, conservative treatment, nephrectomy and various methods of treatment were performed in 21, 12 and 76 cases, respectively Conclusion Strict control of operative complication, proper selection of the operation type and reasonable management of the complication are the important measures to improve the cure rate of upper urinary tract stone, to greatly decrease the occurrence of residual stones and to reduce the possibility of nephrectomy

In order to advance the public hospital reform, the performance tests and management were strengthened to promote the rapid development of the hospital. The status of average daily bed ocupation, the number of outpatients and the natural birth rate increased while the drug proportion declined. Some departments were the top level in Hebei, departments of gynaecology and pediatrics were in the leading level in Tangshan.

The effects of noradrenaline,isoptin.prostaglandin E and indomethacin on the dynamics and the muscloelectrical activities of the ureter were sutdied in dogs.It was found that no-radrenaline exerted excitation on the smooth muscle of the upper ureter,isoptin could remarkably reduce both the electrical and contractile activities of the ureter,prostaglandin E could intensify the activeites of the ureter,and indomethacin could the inhibit the synthesis of intrinsic prostaglandins and in turn relax the smooth muscle of the ureter.

Objective To evaluate the clinical efficacy of ureteroscopy for the diagnosis and treatment of renal colic. Methods A total of 50 cases of renal colic were diagnosed and treated by ureteroscopy. Stones with size smaller than 0 5 cm were removed, but lithoclasty was performed on those stones with size bigger than 0 5 cm. In addition, J shaped catheters or ureteral catheters were indwelt for drainage. Results Successful removal of stones and lithoclasty were achieved in 12 and 30 cases, respectively. No urolithiasis and other lesions were found in 3 cases. Improvement was found in those cases with indwelt catheters. The average stay was 4-5 d. Correlative etiological factors were found in 2 patients by ureteroscopy. Conclusion Transurethral ureteroscopy is an effective and safe method for the diagnosis and treatment of renal colic.